Introduction and objective:
The article focuses mainly on SARS-CoV-2 neurotropism and its consequences for hearing and otolaryngological disorders. The leading hypotheses regarding the mechanisms of the virus internalisation as well as its influence on the nervous system in extenso are presented, as well as the latest available knowledge, after a selective choice of articles relating to the subject.

Brief description of the state of knowledge:
Dizziness, tinnitus and sudden hearing loss are the main symptoms in the organ of hearing and balance, but it is often not possibile to objectively investigate their etiology and make a proper diagnosis. Among the most common causes of hearing disorders, such as vestibular neuritis, sudden sensorineural hearing loss and tinnitus, there are infections, injuries, and diseases that predispose to the occurrence of symptoms of hearing disorders. Despite the numerous possible causes, a high percentage of clinical symptoms still remain without diagnosis.

The global health crisis has provoked a change in the perspective of thinking about infections and the consequences of viral infections; it haalso given rise to a new perception and conceptualisation of the impact of infections on other human systems. The challenge faced by scientists due to this virus is multi-dimensional, and it requires explication and reinterpretation of the knowledge to-date. It even forces us to retrospect the existing explanations of the known disorders, as well as to conduct prospective correlative studies that will help in understand the mechanisms of SARS-CoV-2 pathogenesis, and consequentl, to be able to establish a management pattern in order to prevent the spread of the virus causing the pandemic.

Krasowska S. Neurotropism of SARS-CoV-2 in idiopathic hearing disorders. J Pre-Clin Clin Res. 2021; 15(2): 100–103. doi: 10.26444/jpccr/136055
King AMQ, Adams MJ,Carstens EB, et al. Classification and nomenclature of viruses. In: Virus Taxonomy. Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier. 2012;1326–1327.
Jian S, Yushun W, Luo C, Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020; 117(21): 11727–11734. https://doi:10.1073/pnas.20031....
Englund J, Feuchtinger T, Ljungman P. Viral infections in immunocompromised patients Biol Blood Marrow Transplant Jan;17 2012; S2–5. https//doi:10.1016/j.bbmt.2010.11.008.
Orkide O, Koyuncu I, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013; 13(4): 379–93. https://doi: 10.1016/j.chom.2013.03.010.
Raitgareeva A.R., Bulygin K.V., Gareev I.F., et al. The role of microglia in the development of neurodegeneration. Neurol Sci, 2020. https://doi:10.1007/s10072–020....
Yachou Y, El Idrissi A,Belapasov V, et al. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020; https://doi: 10.1007/s10072–020–04575–3.
Cataldi M, Pignataro G, Taglialatela M. Neurobiology of coronaviruses: Potential relevance for COVID-19. Neurobiol Dis. 2020; 143:105007. https://doi: 10.1016/j.nbd.2020.105007.
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271–280.e8. https://doi:10.1016/j.cell.202....
Cure E, Cure MC, Comment on “Hearing loss and COVID-19: A note”. Am J Otolaryngol. 2020; 41(4):102513. https://doi: 10.1016/j.amjoto.2020.102513.
Briston T, Hicks AR. Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention. Biochem Soc Trans. 2020; 46(4): 829–842. https://doi: 10.1042/BST20180025.
Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngolgy 2020, 102474. https://doi: 10.1016/j.amjoto.2020.102474.
El-Anwar MW, Elzayat S, Fouad YA, ENT manifestation in COVID-19 patients Auris Nasus Larynx: 2020; 559–564 P https://doi:10.1016/j.anl.2020....
Giacomelli A, Pezzati L, Conti F, et al. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; https://doi:10.1093/cid/ciaa33....
Sierpiński R, Pinkas J, Jankowski M, et al. Sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders in 1942 nonhospitalized patients with coronavirus disease 2019 (COVID-19). Pol Arch Intern Med. 2020; 130(6):501–505. https://doi: 10.20452/pamw.15414.
Fidan V. New type of corona virus induced acute otitis media in adult. Am J Otolaryngol. 2020; 41(3):102487. https://doi: 10.1016/j.amjoto.2020.102487.
Kilic O, Kalcioglu MT,Cag Y, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020; 97:208–211. https://doi:10.1016/j.ijid.202....
Almufarrij I, Uus K,Munro KJ. Does coronavirus affect the audio-vestibular system? A rapid systematic review. Int J Audiol. 2020; 59(7): 487–491. https://doi:10.1080/14992027.2....
Degen C, Lenarz T, Willenborg K. Acute Profound Sensorineural Hearing Loss After COVID-19 Pneumonia. Mayo Clin Proc. 2020; 95(8): 1801–1803. https://doi:10.1016/j.mayocp.2....
Mustafa MW. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngolgy. 2020; 102483. https://doi: 10.1016/j.amjoto.2020.102483.
Malayala SV, Raza A. A Case of COVID-19-Induced Vestibular Neuritis. Cureus. 2020; 12(6):e8918. https://doi: 10.7759/cureus.8918.
Brison E, Jacomy H, Desforges M, et al. Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus. J Virol. 2020; 88(3): 1548–63. https://doi:10.1128/JVI.02972–....
Chiappelli F, Khakshooy A,Greenberg G. COVID-19 Immunopathology and Immunotherapy. Bioinformation. 2020; 16(3):219–222. https://doi:10.6026/9732063001....
Fiani B, Covarrubias C,Desai A, et al. A Contemporary Review of Neurological Sequelae of COVID-19. Front Neurol.2020; 11:640. https://doi:10.3389/fneur.2020....
Yu C, Zhou M, Liu Y, et al. Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study. Virulence.2020; 1006–1014. https://doi:10.1080/21505594.2....
Division of Viral Diseases. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). (Updated Feb. 16, 2021).
European Centre for Disease Prevention and Control (ECDC). Transmission of COVID-19. ECDC. (Update 30 June 2020).
Almufarrij I, Uus K, Munro K. Does coronavirus affect the audio-vestibular system? A rapid systematic review. Int J Audiol.2020; 59(7): 487–491. https://doi:10.1080/14992027.2....
Freni F, Meduri A, Munro G, et al. Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2. Am J Otolaryngol. 2020; 41(5):102612. https://doi: 10.1016/j.amjoto.2020.102612.
Hasanagic S, Serdarevic F. Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond. Eur Respir J. 2020; 56(2): 2001610. https://doi:10.1183/13993003.0....
Arshad S, Kilgore P, Chaudhry ZS, et al. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalised with COVID-19.Int J Infect Dis. 2020; 97:396–403. https://doi:10.1016/j.ijid.202....
Li Z, Wang X, Cao D, et al. Rapid review for the anti-coronavirus effect of remdesivir. Drug Discov Ther.2020;14(2):73–76. https://doi:10.5582/ddt.2020.0....
Rajendran K,Krishnasamy N, Rathinam J, et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol.2020; 1:10. https://doi: 10.1002/jmv.25961.
Ciorba A, Corazzi V, Skarżyński PH, et al. Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic! Int J Immunopathol Pharmacol.2020; 34. https://doi:10.1177/2058738420....
Journals System - logo
Scroll to top